期刊文献+

肿瘤干细胞与肿瘤治疗 被引量:2

Tumor Stem Cells and Tumor Therapy
下载PDF
导出
摘要 肿瘤可看作是由功能异质性的细胞群体所组成的,具有不定增殖能力的异常器官。最近提出的肿瘤干细胞学说认为肿瘤起源于干细胞,肿瘤生长是肿瘤组织中极少量具有特殊细胞表面标志的肿瘤干细胞增殖的结果。因此治疗的关键应是针对肿瘤干细胞,通过靶向肿瘤干细胞及其异常调节的信号转导通路来治疗肿瘤。这对传统的治疗方式提出了巨大挑战,也为有效地根治肿瘤开辟了新的思路。 Tumors can be viewed as an abnormal organ which comprise a heterogenous population of cells with marked difference in their proliferative potential and the ability to reconstitute the tumor upon transplantation. The implication of the cancer stem- cell hypothesis is that tumor origins from the stem cells,and is a disease of stem cells. The growth of tumor is the result of a minor population of cancer stem cells' which have the special cell surface mark. Therefore the key of tumor treatment should aim at the cancer stem cells. This new model of cancer is a huge challenge to the traditional cancer treatments, and cancer stem cell therapy could indeed be a shining light on the cancer research borizon.
出处 《医学与哲学》 北大核心 2005年第8期30-31,共2页 Medicine and Philosophy
关键词 肿瘤 肿瘤干细胞 治疗 新观念 tumor tumor stem cells therapy new idea
  • 相关文献

参考文献11

  • 1REYA T,MORRISON S J,CLARKE M F, et al. Stem cells, cancer,and cancer stem cells[J]. Nature,2001,414(6859) : 105 - 111.
  • 2BONNET D, DICK J E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J ].Nat Med , 1997,3(7) :730 - 737.
  • 3BLAIR A, HOGGE D E, AILLES L E, et al. Lack of expression of Thy - 1 (CD90) on acute myeloid leukemia cells with long - term proliferative ability in vitro and in vivo[J]. Blood , 1997,89:3 104-3 112.
  • 4AL - HAJJ M, WICHA M S, BENITO - HE.MANDEZ A, et al.Prospective identification of tumorigenic breast cancer cells [ J ]. Proc Natl Acad Sci USA, 2003,100:3 983-3 988.
  • 5SINGH S K, HAWKINS C, CLARKE I D, et al. Identification of human brain turnout initiating cells[J]. Nature, 2004, 432(7015):396 - 401.
  • 6DOMEN J, G/hNDY K L, WEISSMANN I L. Systemic overexpression of BCL2 in the hematopoetic system protects transgenic mice from the consequences of lethal irradiation[J]. Blood , 1998, 91 (7) : 2 272- 2 282.
  • 7ZHOU S, SCHUETZ J D, BUNTING K D, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side- population phenotype [J ]. Nat Med, 2001, 7(9) : 1 028 - 1 034.
  • 8ABRAHAM B K, FRITZ P, MCCLELLAN M, et al. Prevalence of CD44 +/CD24 -/low cells in breast cancer may not be associated with clinical outcome butrnay favor distant metastasis[J]. Clin Cancer Res,2005, 11(3): 1 154 -1 159.
  • 9AL - HAJJ M, BECKER MW, WICHA M , et al. Therapeutic implication of cancer stem cells[J ], Curr Opin in Genet Dev, 2004,14 ( 1 ) :43 - 47.
  • 10PARDAL R, CLARKE M F, MORRSON S J. Applying the prineiples of stem - cell biology to cancer [ J ]. Nat Rev Cancer. 2003 , 3 ( 12 ) :895 - 902.

同被引文献11

  • 1黄盛东,刘晓红,白辰光,龚德军,袁扬,刘延玲.A549肺癌细胞株中肿瘤干细胞与克隆形成的关系[J].中华实验外科杂志,2006,23(9):1053-1055. 被引量:14
  • 2黄云超,王昆.肺癌诊治的哲学思考[J].中国肺癌杂志,2006,9(6):564-565. 被引量:2
  • 3Houghton J,Morozov A,Smimova I.Stem cells and cancer[J].Semin Cancer Biol,2007(17):191-203.
  • 4Bapat SA.Evolution of cancer stem cells[J].Semin Cancer Bi ol.2007,17(3):204-213.
  • 5Makino S.The role of tumor stem-cells in regrowth of the tumor following drastic applications[J].Acta Unio Int Contra Can crum.1959;15(Supp]I):196-198.
  • 6Reya T,Morrison SJ,Clarke MF,et al.Stem cells,cancer,and cancer stem cell[J].Nature,2001,414:105-111.
  • 7Shipitsin M,Campbell LL,Argani P,et al.Molecular definition of breast tumor heterogenetity[J].Cancer Cell,2007,11(3):259-273.
  • 8Kelly PN,Dakic A,Adams JM,et al.Tumorgrowth need not be driven by rare cancer stem cells[J].Science,2007,317(5836):337.
  • 9Clarks MF,Dick JE,Dirks PB,et al.Cancer stem cells-per spectives on current status and future directions:AACR work shop on cancer stem cells[J].Cancer Res,2006,66(19):9339-9344.
  • 10文加斌,张阳,王丽萍,张华,程现昆.肺癌肿瘤干细胞研究的科学方法论[J].医学与哲学(B),2008,29(5):72-73. 被引量:1

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部